3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
87
Leukemia
49
Leukemia, Biphenotypic, Acute
14
Burkitt Lymphoma
14
Lymphoma
13
Leukemia, Myeloid, Acute
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Recurrence
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Neoplasm, Residual
3
Lymphoma, Non-Hodgkin
3
Anemia, Refractory, with Excess of Blasts
3
Myeloproliferative Disorders
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia, Eosinophilic, Acute
2
Down Syndrome
2
Dendritic Cell Sarcoma, Interdigitating
2
Anemia, Refractory
2
Thrombocytopenia
1
Sarcoma, Myeloid
1
Neutropenia
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Doxorubicin
2
hydrocortisone hemisuccinate
1
Vincristine
1
Razoxane
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Mercaptopurine
1
Medical History Taking
1
Leucovorin
1
Laser-Doppler Flowmetry
1
Hydrocortisone
1
Exercise
1
Electrocardiography
1
Echocardiography, Stress
1
Dexrazoxane
1
Cytarabine
1
Blood Cell Count
1
Asparaginase
1
Anthropometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Asparaginase
×
Other hematologic neoplasm
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled